rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kenneth F. Buechler

Director

Company insider

Files Form 4 as: Director, QuidelOrtho; Director, Quidel Corp /de/; Director, Sequenom; President & Chief Scientific O, Biosite.

In numbers

Trades disclosed
279
Buys
2
Sells
8
Bought
$150K
Sold
$6.3M
Companies
4
Companies where not an officer
4
First trade
17 Nov 2006
Last trade
25 Jun 2026
Last filed
29 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
QDEL QuidelOrthoDirector · Diagnostics & Labs · last 25 Jun 20260 buys · 1 sell
Quidel Corp /de/Director · last 27 May 20220 buys · 6 sells
SequenomDirector · last 7 Sep 20162 buys · 0 sells
BiositeDirector · last 29 Jun 20070 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—15,532 at $0.00filing
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—12,204 at $0.00filing
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—3,661 at $0.00filing
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—15,532 at $0.00filing
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—12,204 at $0.00filing
25 Jun 2026filed 29 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code A—3,661 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—1,659 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—497 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,659 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,659 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—497 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—497 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—1,659 at $0.00filing
6 Jun 2026filed 9 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—497 at $0.00filing
29 May 2026filed 2 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—6,829 at $0.00filing
29 May 2026filed 2 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—6,829 at $0.00filing
29 May 2026filed 2 Jun 2026QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—6,829 at $0.00filing
29 May 2026filed 2 Jun 2026QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code A—6,829 at $0.00filing
15 Jul 2025filed 17 Jul 2025QDEL QuidelOrthooption or derivative · Diagnostics & LabsSEC FORM 4 Code M—9,215 at $0.00filing
15 Jul 2025filed 17 Jul 2025QDEL QuidelOrthoDiagnostics & LabsSEC FORM 4 Code M$145K9,215 at $15.74filing

Sectors

Health Care1
Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Jonathan Philip SiegristEVP of R&D & CTO · EVP of R&D & CTO at QuidelOrtho, filing Form 4 there in the last year
Ronald Lee BowmanChief Human Resources Officer · Chief Human Resources Officer at QuidelOrtho, filing Form 4 there in the last year
Bryan Michael HansonEVP Global Port. Mgmt & Mkting · EVP Global Port. Mgmt & Mkting at QuidelOrtho, filing Form 4 there in the last year
Micah W. YoungChief Financial Officer · Chief Financial Officer at QuidelOrtho, filing Form 4 there in the last year
Evelyn S. DilsaverDirector · Director at QuidelOrtho, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded QDEL in the last 90 days